Emergent BioSolutions
EBS
#7398
Rank
NZ$0.72 B
Marketcap
NZ$13.59
Share price
-26.58%
Change (1 day)
9.69%
Change (1 year)

Emergent BioSolutions (EBS) - P/B ratio

P/B ratio as of February 2026 : 0.7574

According to Emergent BioSolutions 's latest financial reports the company has a price-to-book ratio of 0.587736.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Emergent BioSolutions - P/B ratio (from 2006 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-311.1523.45%
2024-12-310.9281383.96%
2023-12-310.1918-54.83%
2022-12-310.4246-70.74%
2021-12-311.45-55.78%
2020-12-313.2828.07%
2019-12-312.56-14.65%
2018-12-313.0018.13%
2017-12-312.5413.93%
2016-12-312.23-6.62%
2015-12-312.3928.7%
2014-12-311.867.84%
2013-12-311.7232.27%
2012-12-311.30-10.43%
2011-12-311.45-33.92%
2010-12-312.2027.95%
2009-12-311.72-56.15%
2008-12-313.92345.58%
2007-12-310.8795-60.46%
2006-12-312.22
2005-12-31N/A
2004-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.68 121.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.95 686.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
5.59 638.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
1.56 106.05%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
2.25 197.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.30 335.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.88 544.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel